Research ArticleArticle

Patient Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA and OMERACT Study

ALBERTO CAULI, DAFNA D. GLADMAN, ALESSANDRO MATHIEU, IGNAZIO OLIVIERI, GIOVANNI PORRU, PAUL P. TAK, CLAUDIA SARDU, ILONA UJFALUSSY, RAFFAELE SCARPA, ANTONIO MARCHESONI, WILLIAM J. TAYLOR, ANTONIO SPADARO, JOSE L. FERNÀNDEZ-SUEIRO, CARLO SALVARANI, JOACHIM R. KALDEN, ENNIO LUBRANO, SUELI CARNEIRO, FRANCESCA DESIATI, JOHN A. FLYNN, SALVATORE D’ANGELO, ALESSANDRA VACCA, ARNO W.R. VAN KUIJK, MARIA GRAZIA CATANOSO, MATHIAS GRUENKE, ROSARIO PELUSO, WENDY J. PARSONS, NICOLA FERRARA, PAOLO CONTU, PHILIP S. HELLIWELL, PHILIP J. MEASE for the GRAPPA 3PPsA Study Group and PHILIP J. MEASE for the GRAPPA 3PPsA Study Group
The Journal of Rheumatology May 2011, 38 (5) 898-903; DOI: https://doi.org/10.3899/jrheum.100857

REFERENCES

  1. 1.↵
    1. Wright V,
    2. Moll JMH
    . Seronegative polyarthritis. New York: North-Holland Publishing; 1976.
  2. 2.↵
    1. Harris ED,
    2. Budd RC,
    3. Firestein GS,
    4. Genovese MC,
    5. Sergent JS,
    6. Ruddy S,
    7. Sledge CB
    1. Gladman DD
    . Psoriatic arthritis. In: Harris ED, Budd RC, Firestein GS, Genovese MC, Sergent JS, Ruddy S, Sledge CB, editors. Kelley’s textbook of rheumatology. 7th ed. Philadelphia: W.B. Saunders; 2005:1155–64.
  3. 3.↵
    1. Taylor WJ,
    2. Gladman DD,
    3. Helliwell PS,
    4. Marchesoni A,
    5. Mease P,
    6. Mielants H,
    7. et al.
    Classification criteria for psoriatic arthritis. Arthritis Rheum 2006;54:2665–73.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Gladman DD,
    2. Helliwell P,
    3. Mease PJ,
    4. Nash P,
    5. Ritchlin C,
    6. Taylor W
    . Assessment of patients with psoriatic arthritis. A review of currently available measures. Arthritis Rheum 2004;50:24–35.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Mease PJ,
    2. Antoni CE
    . Psoriatic arthritis treatment: biological response modifiers. Ann Rheum Dis 2005;64 Suppl 2:ii78–ii82.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Mease PJ,
    2. Gladman DD,
    3. Krueger GG
    . Prologue: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Ann Rheum Dis 2005;64:ii1–ii2.
    OpenUrlFREE Full Text
  7. 7.↵
    1. Taylor WJ
    . Preliminary identification of core domains for outcome studies in psoriatic arthritis using Delphi methods. Ann Rheum Dis 2005;64 Suppl 2:ii110–ii112.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Gladman DD
    . Consensus exercise on domains in psoriatic arthritis. Ann Rheum Dis 2005;64 Suppl 2:ii113–ii114.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Gladman DD,
    2. Mease P,
    3. Krueger G,
    4. van der Heijde D,
    5. Antoni C,
    6. Helliwell P,
    7. et al.
    Outcome measures in psoriatic arthritis (PsA): OMERACT VII Psoriatic Arthritis Workshop. J Rheumatol 2005;32:2262–9.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Gladman DD,
    2. Mease P,
    3. Healy P,
    4. Helliwell PS,
    5. Fitzgerald O,
    6. Cauli A,
    7. et al.
    Outcome measures in psoriatic arthritis. J Rheumatol 2007;34:1159–66.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Gladman DD,
    2. Mease P,
    3. Strand V,
    4. Healy P,
    5. Helliwell PS,
    6. Fitzgerald O,
    7. et al.
    Consensus on a core set of domains for psoriatic arthritis. J Rheumatol 2007;34:1159–66.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Zigmond AS,
    2. Snaith RP
    . The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scand 1983;67:361–70.
    OpenUrlPubMed
  13. 13.↵
    1. Gladman DD,
    2. Cook RJ,
    3. Schentag C,
    4. Feletar M,
    5. Inman RI,
    6. Hitchon C,
    7. et al.
    The clinical assessment of patients with psoriatic arthritis: results of a validation study of the SpondyloArthritis Research Consortium of Canada (SPARCC). J Rheumatol 2004;31:1126–31.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Fredriksson T,
    2. Pettersson U.
     Severe psoriasis — oral therapy with a new retinoid. Dermatologica 1978;157:238–44.
    OpenUrlPubMed
  15. 15.↵
    1. Boehncke WH,
    2. Adebajo A,
    3. Cauli A,
    4. Nash P,
    5. Salvarani C,
    6. Kavanaugh AF
    . The GRAPPA 2007 initiative for quality in psoriasis and psoriatic arthritis. J Rheumatol 2008;35:1431–3.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Felson DT,
    2. Anderson JJ,
    3. Boers M,
    4. Bombardier C,
    5. Furst D,
    6. Goldsmith C,
    7. et al.
    American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727–35.
    OpenUrlPubMed
  17. 17.↵
    1. van Gestel AM,
    2. Prevoo MLL,
    3. van ’t Hof MA,
    4. van Rijswijk MH,
    5. van de Putte LBA,
    6. van Riel PLCM
    . Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization / International League Against Rheumatism criteria. Arthritis Rheum 1996;39:34–40.
    OpenUrlPubMed
  18. 18.↵
    1. Clegg DO,
    2. Reda DJ,
    3. Mejias E,
    4. Cannon GW,
    5. Weisman MH,
    6. Taylor T,
    7. et al.
    Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 1996;39:2013–20.
    OpenUrlPubMed
  19. 19.↵
    1. Bellamy N,
    2. Campbell J,
    3. Syrotuik J
    . Comparative study of self-rating pain scales in rheumatoid arthritis patients. Curr Med Res Opin 1999;15:121–7.
    OpenUrlPubMed
  20. 20.↵
    1. Bellamy N,
    2. Campbell J,
    3. Syrotuik J
    . Comparative study of self-rating pain scales in osteoarthritis patients. Curr Med Res Opin 1999;15:113–9.
    OpenUrlPubMed
  21. 21.↵
    1. Brockbank JE,
    2. Stein M,
    3. Schentag CT,
    4. Gladman D
    . Dactylitis in psoriatic arthritis: a marker for disease severity. Ann Rheum Dis 2005;64:188–90.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Oriente P,
    2. Biondi-Oriente C,
    3. Scarpa R
    . Psoriatic arthritis. Clinical manifestations. Baillieres Clin Rheumatol 1994;8:227–94.
    OpenUrl
  23. 23.↵
    1. Kelley WN,
    2. Harris ED,
    3. Ruddy S
    . Textbook of rheumatology. 3rd ed. Philadelphia: WB Saunders; 1989.
  24. 24.↵
    1. Spadaro A,
    2. Riccieri V,
    3. Sili-Scavalli A,
    4. Sensi F,
    5. Taccari E,
    6. Zoppini A
    . Comparison of cyclosporine-A and methotrexate in the treatment of psoriatic arthritis: a one year prospective study. Clin Exp Rheumatol 1995;13:589–93.
    OpenUrlPubMed
  25. 25.↵
    1. Kaltwasser JP,
    2. Nash P,
    3. Gladman D,
    4. Rosen CF,
    5. Behrens F,
    6. Jones P,
    7. et al.
    Treatment of Psoriatic Arthritis Study Group. Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial. Arthritis Rheum 2004;50:1939–50.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Pitzalis C,
    2. Cauli A,
    3. Pipitone N,
    4. Smith C,
    5. Barker J,
    6. Marchesoni A,
    7. et al.
    Cutaneous lymphocyte antigen-positive T lymphocytes preferentially migrate to the skin but not to the joint in psoriatic arthritis. Arthritis Rheum 1996;39:137–45.
    OpenUrlPubMed
  27. 27.↵
    1. Cauli A,
    2. Pitzalis C,
    3. Yanni G,
    4. Hawad M,
    5. Panayi GS
    . CD1 positive antigen presenting cells in psoriatic and rheumatoid arthritis. Rheumatology 2000;6:666–73.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

 Request Permissions

Bookmark this article

Jump to section